These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5278257)

  • 1. Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.
    Wardell WM; McQueen EG
    N Z Med J; 1970 Dec; 72(463):393-6. PubMed ID: 5278257
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological assay versus spectrophotometry for determination of rifampicin in urine.
    George J; Bhatia VN; Balakrishnan S
    Indian J Lepr; 1988 Jan; 60(1):47-52. PubMed ID: 3060546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifampicin levels in blood, urine and kidney tissue in patients with renal tuberculosis].
    Mochalova TP; Kanevskaia SS; Danilova NK
    Antibiotiki; 1973 Feb; 18(2):178-80. PubMed ID: 4776397
    [No Abstract]   [Full Text] [Related]  

  • 5. The renal elimination of rifampicin as a function of the oral dose. A convenient way to assess relative bioavailability.
    Brechbühler S; Fluehler H; Riess W; Theobald W
    Arzneimittelforschung; 1978; 28(3):480-3. PubMed ID: 580761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Developement of serum and urine concentrations of rifampicin during treatment].
    Pechère JC; Tancrède C
    Pathol Biol (Paris); 1969 Feb; 17(3):155-8. PubMed ID: 4892933
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
    Pillai G; Ellard GA; Smith PJ; Fourie PB
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 9. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
    Gurumurthy P; Ramachandran G; Vijayalakshmi S; Kumar AK; Venkatesan P; Chandrasekaran V; Vjayasekaran V; Kumaraswami V; Prabhakar R
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):119-25. PubMed ID: 10091876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R; Singh I; Kaur KJ; Kaul CL
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of rifampicin bioavailabilities of fixed-dose combinations of anti-tuberculosis drugs: procedures for ensuring laboratory proficiency.
    Ellard GA
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S322-4; discussion S351-2. PubMed ID: 10593711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and saliva concentrations of rifampicin in man after oral administration.
    Orisakwe OE; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):45-9. PubMed ID: 9239804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin blood levels in man.
    Verbist L
    Acta Tuberc Pneumol Belg; 1969; 60(3):288-98. PubMed ID: 5373653
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic usefulness of a chemical method of determination of rifampicin in urine].
    Janiszewski M; Szewczyk I
    Gruzlica; 1975 Feb; 43(2):157-62. PubMed ID: 1112531
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of rifampicin serum levels following its administration before breakfast and 3 hours after breakfast].
    Zwolska-Kwiek Z; Lawicka E; Wasowska H
    Gruzlica; 1975 Feb; 43(2):151-6. PubMed ID: 1112530
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methods of determination of rifampicin in the urine].
    Ioffe RA
    Antibiotiki; 1973 Sep; 18(9):799-802. PubMed ID: 4761951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.